About us


We are based at Oxford University, we have extensive collaborations with the industry which allowed us to survey therapeutic needs for computational antibody tools, test and deploy them in collaborating/client institutions, making impactful difference.


We have been developing computational tools to facilitate antibody design since 2009. Our software was created on the basis of ongoing collaborations with UCB, Roche, Medimmune, GSK and others. We currently offer tools for